CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Clinical trials for CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to deepen remission in early CML
Disease control Recruiting nowThis study tests whether adding ASTX727 to the standard drug dasatinib can better control chronic myeloid leukemia (CML) in newly diagnosed patients. About 70 adults with a specific genetic marker (Philadelphia chromosome) will receive both pills. The goal is to see if the combin…
Matched conditions: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Your personality could be key to sticking with CML treatment
Knowledge-focused Recruiting nowThis study explores whether a person's personality traits influence how well they take their daily leukemia pills. Researchers will interview 75 adults with chronic myeloid leukemia and use questionnaires to measure medication adherence, personality, and quality of life. The goal…
Matched conditions: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC